Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Buy
52
LRCX Quote, Financials, Valuation and Earnings
Last price:
$77.31
Seasonality move
:
6.57%
Day range:
$77.11 - $79.14
52-week range:
$68.87 - $113.00
Dividend yield:
1.14%
P/E ratio:
23.79x
P/S ratio:
6.31x
P/B ratio:
11.41x
Volume:
9.5M
Avg. volume:
13M
1-year change:
-13.95%
Market cap:
$100.5B
Revenue:
$14.9B
EPS (TTM):
$3.29
Lam Research Number of Institutional Trades
Lam Research Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$243.2B
(Last 6 Months)
Current Institutional Ownership Percentage
91.05%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$69B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Lam Research Institutional Ownership
-
What Percentage Of LRCX Is Owned by Institutions?
91.05% of LRCX is owned by institutions.
-
How Many Institutions Own LRCX Shares?
Lam Research stock is owned by 2,991 institutional shareholders at this time.
-
Have Institutions Been Buying LRCX Stock?
Yes, institutions have bought 3B shares of LRCX in the last quarter.
-
Have Institutions Been Selling LRCX Stock?
Yes, institutions have sold 790.9M shares of LRCX over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
